Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses ...

MoonLake jumps 18% after a report says MRK made a $3 billion-plus offer earlier this year, with talks potentially set to resume.

BioVaxys Technology Corp. (OTC:BVAXF) issued a comprehensive corporate update, detailing its strategic initiatives.

Today’s Forbes Daily newsletter covers higher steel and aluminum tariffs, Americans sour on Elon Musk, Meta's nuclear deal, ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

WELLESLEY, Mass., June 4, 2025 /PRNewswire/ -- Sun Life, the nation's leading independent stop-loss provider for self-funded employers, today released its 13th annual high-cost claim and injectable ...

The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...

Delhi Police has busted a racket selling spurious anti-cancer drugs and arrested six men who targeted patients through social media by offering costly medicines at discounted rates, an official said ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...